Status:

ACTIVE_NOT_RECRUITING

Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation

Lead Sponsor:

Memorial Sloan Kettering Cancer Center

Conditions:

Breast Cancer

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this study is to find out how often the researchers can avoid an ALND in patients with early-stage, node-positive HR+/HER2- breast cancer who are having upfront surgery. The study resea...

Eligibility Criteria

Inclusion

  • Patients aged ≥18 years with biopsy-proven invasive breast cancer
  • Patients with cTx, cT1, or cT2 tumors with palpable ipsilateral mobile adenopathy of level I/II axillary nodes with biopsy-proven (either by pre-operative biopsy or intraoperative frozen section) nodal metastasis (cN1) who are undergoing upfront surgery
  • Patients with tumors of the HR+/HER2- subtype, defined as:
  • HR+: Positive for estrogen receptor and/or progesterone receptor staining, indicated by ≥1% immunoreactive tumor nuclei
  • HER2-: Immunohistochemistry assay demonstrating no or faint staining in ≤10% of tumor cells (IHC 0 or 1+) or negative by dual probe in situ hybridization assay

Exclusion

  • Patients with prior ipsilateral breast cancer
  • Patients who are pregnant
  • Patients with stage IV disease at presentation
  • Patients with advanced regional disease (cN2/cN3)

Key Trial Info

Start Date :

April 20 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

April 1 2026

Estimated Enrollment :

78 Patients enrolled

Trial Details

Trial ID

NCT04854005

Start Date

April 20 2021

End Date

April 1 2026

Last Update

May 6 2025

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

Hartford Healthcare Cancer Alliance (Data collection only)

Hartford, Connecticut, United States, 06102

2

University of Michigan (Data Collection Only)

Ann Arbor, Michigan, United States, 48109

3

Memorial Sloan Kettering Basking Ridge (Consent Only)

Basking Ridge, New Jersey, United States, 07920

4

Memorial Sloan Kettering Monmouth (All Protocol Activities)

Middletown, New Jersey, United States, 07748